| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |